1
|
Siegel RL, Miller KD and Jemal A: Cancer
Statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
2
|
Munro A, Codde J, Spilsbury K, Steel N,
Stewart CJ, Salfinger SG, Tan J, Mohan GR, Leung Y, Semmens JB, et
al: Risk of persistent and recurrent cervical neoplasia following
incidentally detected adenocarcinoma in situ. Am J Obstet Gynecol.
216:272.e1–272.e7. 2017. View Article : Google Scholar
|
3
|
Kim S-W, Chun M, Ryu H-S, Chang SJ, Kong
TW, Lee EJ, Lee YH and Oh YT: Salvage radiotherapy with or without
concurrent chemotherapy for pelvic recurrence after hysterectomy
alone for early-stage uterine cervical cancer. Strahlenther Onkol.
193:534–542. 2017. View Article : Google Scholar : PubMed/NCBI
|
4
|
Li C, Liu W and Cheng Y: Prognostic
significance of metastatic lymph node ratio in squamous cell
carcinoma of the cervix. Onco Targets Ther. 9:3791–3797.
2016.PubMed/NCBI
|
5
|
Wang XJ, Xiong Y, Ma ZB, Xia JC and Li YF:
The expression and prognostic value of protein tyrosine kinase 6 in
early-stage cervical squamous cell cancer. Chin J Cancer.
35:542016. View Article : Google Scholar : PubMed/NCBI
|
6
|
Li J, Wu MF, Lu HW, Chen Q, Lin ZQ and
Wang LJ: Pretreatment serum lactate dehydrogenase is an independent
prognostic factor for patients receiving neoadjuvant chemotherapy
for locally advanced cervical cancer. Cancer Med. 5:1863–1872.
2016. View
Article : Google Scholar : PubMed/NCBI
|
7
|
Fleming ND, Frumovitz M, Schmeler KM, dos
Reis R, Munsell MF, Eifel PJ, Soliman PT, Nick AM, Westin SN and
Ramirez PT: Significance of lymph node ratio in defining risk
category in node-positive early stage cervical cancer. Gynecol
Oncol. 136:48–53. 2015. View Article : Google Scholar :
|
8
|
Zhang WN, Li W, Wang XL, Hu Z, Zhu D, Ding
WC, Liu D, Li KZ, Ma D and Wang H: CLDN1 expression in cervical
cancer cells is related to tumor invasion and metastasis.
Oncotarget. 7:87449–87461. 2016. View Article : Google Scholar : PubMed/NCBI
|
9
|
Chung IH, Wu TI, Liao CJ, Hu JY, Lin YH,
Tai PJ, Lai CH and Lin KH: Overexpression of lipocalin 2 in human
cervical cancer enhances tumor invasion. Oncotarget. 7:11113–11126.
2016. View Article : Google Scholar : PubMed/NCBI
|
10
|
Issemann I and Green S: Activation of a
member of the steroid hormone receptor superfamily by peroxisome
proliferators. Nature. 347:645–650. 1990. View Article : Google Scholar : PubMed/NCBI
|
11
|
Berger J and Moller DE: The mechanisms of
action of PPARs. Annu Rev Med. 53:409–435. 2002. View Article : Google Scholar : PubMed/NCBI
|
12
|
Mandard S and Patsouris D: Nuclear control
of the inflammatory response in mammals by peroxisome
proliferator-activated receptors. PPAR Res. 2013:6138642013.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Xin X, Yang S, Kowalski J and Gerritsen
ME: Peroxisome proliferator-activated receptor gamma ligands are
potent inhibitors of angiogenesis in vitro and in vivo. J Biol
Chem. 274:9116–9121. 1999. View Article : Google Scholar : PubMed/NCBI
|
14
|
Sato M: Peroxisome proliferator activated
receptor ligands and angiogenesis. Nihon Rinsho. 63:603–608.
2005.In Japanese. PubMed/NCBI
|
15
|
Liu M, Hu Y, Zhang MF, Luo KJ, Xie XY, Wen
J, Fu JH and Yang H: MMP1 promotes tumor growth and metastasis in
esophageal squamous cell carcinoma. Cancer Lett. 377:97–104. 2016.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Ozden F, Saygin C, Uzunaslan D, Onal B,
Durak H and Aki H: Expression of MMP-1, MMP-9 and TIMP-2 in
prostate carcinoma and their influence on prognosis and survival. J
Cancer Res Clin Oncol. 139:1373–1382. 2013. View Article : Google Scholar : PubMed/NCBI
|
17
|
Shin DH, Dier U, Melendez JA and Hempel N:
Regulation of MMP-1 expression in response to hypoxia is dependent
on the intracellular redox status of metastatic bladder cancer
cells. Biochim Biophys Acta. 1852:2593–2602. 2015. View Article : Google Scholar : PubMed/NCBI
|
18
|
Cai QW, Li J, Li XQ, Wang JQ and Huang Y:
Expression of STAT3, MMP-1 and TIMP-1 in gastric cancer and
correlation with pathological features. Mol Med Rep. 5:1438–1442.
2012.PubMed/NCBI
|
19
|
Juncker-Jensen A, Deryugina EI, Rimann I,
Zajac E, Kupriyanova TA, Engelholm LH and Quigley JP: Tumor MMP-1
activates endothelial PAR1 to facilitate vascular intravasation and
metastatic dissemination. Cancer Res. 73:4196–4211. 2013.
View Article : Google Scholar : PubMed/NCBI
|
20
|
Anand M, Van Meter TE and Fillmore HL:
Epidermal growth factor induces matrix metalloproteinase-1 (MMP-1)
expression and invasion in glioma cell lines via the MAPK pathway.
J Neurooncol. 104:679–687. 2011. View Article : Google Scholar : PubMed/NCBI
|
21
|
Scotto L, Narayan G, Nandula SV,
Arias-Pulido H, Subramaniyam S, Schneider A, Kaufmann AM, Wright
JD, Pothuri B, Mansukhani M, et al: Identification of copy number
gain and overexpressed genes on chromosome arm 20q by an
integrative genomic approach in cervical cancer: Potential role in
progression. Genes Chromosomes Cancer. 47:755–765. 2008. View Article : Google Scholar : PubMed/NCBI
|
22
|
Robinson MD, McCarthy DJ and Smyth GK:
edgeR: A Bioconductor package for differential expression analysis
of digital gene expression data. Bioinformatics. 26:139–140. 2010.
View Article : Google Scholar
|
23
|
McCarthy DJ, Chen Y and Smyth GK:
Differential expression analysis of multifactor RNA-Seq experiments
with respect to biological variation. Nucleic Acids Res.
40:4288–4297. 2012. View Article : Google Scholar : PubMed/NCBI
|
24
|
Huber W, Carey VJ, Gentleman R and Anders
S: Orchestrating high-throughput genomic analysis with
Bioconductor. Nat Methods. 12:115–121. 2015. View Article : Google Scholar : PubMed/NCBI
|
25
|
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW,
Shi W and Smyth GK: limma powers differential expression analyses
for RNA-sequencing and microarray studies. Nucleic Acids Res.
43:e472015. View Article : Google Scholar : PubMed/NCBI
|
26
|
Mootha VK, Lindgren CM, Eriksson KF,
Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E,
Ridderstråle M, Laurila E, et al: PGC-1alpha-responsive genes
involved in oxidative phosphorylation are coordinately
downregulated in human diabetes. Nat Genet. 34:267–273. 2003.
View Article : Google Scholar : PubMed/NCBI
|
27
|
Subramanian A, Tamayo P, Mootha VK,
Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub
TR, Lander ES, et al: Gene set enrichment analysis: A
knowledge-based approach for interpreting genome-wide expression
profiles. Proc Natl Acad Sci USA. 102:15545–15550. 2005. View Article : Google Scholar : PubMed/NCBI
|
28
|
Aubrey BJ, Kelly GL, Kueh AJ, Brennan MS,
O'Connor L, Milla L, Wilcox S, Tai L, Strasser A and Herold MJ: An
inducible lentiviral guide RNA platform enables the identification
of tumor-essential genes and tumor-promoting mutations in vivo.
Cell Reports. 10:1422–1432. 2015. View Article : Google Scholar
|
29
|
Li X, Tian R, Gao H, Yang Y, Williams BRG,
Gantier MP, McMillan NAJ, Xu D, Hu Y and Gao Y: Identification of a
histone family gene signature for predicting the prognosis of
cervical cancer patients. Sci Rep. 7:164952017. View Article : Google Scholar : PubMed/NCBI
|
30
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
31
|
Michalik L, Desvergne B and Wahli W:
Peroxisome-proliferator-activated receptors and cancers: Complex
stories. Nat Rev Cancer. 4:61–70. 2004. View Article : Google Scholar : PubMed/NCBI
|
32
|
Cangemi A, Fanale D, Rinaldi G, Bazan V,
Galvano A, Perez A, Barraco N, Massihnia D, Castiglia M, Vieni S,
et al: Dietary restriction: Could it be considered as speed bump on
tumor progression road. Tumour Biol. 37:7109–7118. 2016. View Article : Google Scholar : PubMed/NCBI
|
33
|
O'Sullivan KE, Reynolds JV, O'Hanlon C,
O'Sullivan JN and Lysaght J: Could signal transducer and activator
of transcription 3 be a therapeutic target in obesity-related
gastrointestinal malignancy. J Gastrointest Cancer. 45:1–11. 2014.
View Article : Google Scholar
|
34
|
Zhu P, Goh YY, Chin HF, Kersten S and Tan
NS: Angiopoietin-like 4: A decade of research. Biosci Rep.
32:211–219. 2012. View Article : Google Scholar : PubMed/NCBI
|
35
|
Pencik J, Schlederer M, Gruber W, Unger C,
Walker SM, Chalaris A, Marié IJ, Hassler MR, Javaheri T, Aksoy O,
et al: STAT3 regulated ARF expression suppresses prostate cancer
metastasis. Nat Commun. 6:77362015. View Article : Google Scholar : PubMed/NCBI
|
36
|
Zheng T, Hong X, Wang J, Pei T, Liang Y,
Yin D, Song R, Song X, Lu Z, Qi S, et al: Gankyrin promotes tumor
growth and metastasis through activation of IL-6/STAT3 signaling in
human cholangiocarcinoma. Hepatology. 59:935–946. 2014. View Article : Google Scholar
|
37
|
Trombetta A, Maggiora M, Martinasso G,
Cotogni P, Canuto RA and Muzio G: Arachidonic and docosahexaenoic
acids reduce the growth of A549 human lung-tumor cells increasing
lipid peroxidation and PPARs. Chem Biol Interact. 165:239–250.
2007. View Article : Google Scholar : PubMed/NCBI
|
38
|
Margeli A, Kouraklis G and Theocharis S:
Peroxisome proliferator activated receptor-gamma (PPAR-gamma)
ligands and angiogenesis. Angiogenesis. 6:165–169. 2003. View Article : Google Scholar
|
39
|
George A, Ranganathan K and Rao UK:
Expression of MMP-1 in histopathological different grades of oral
squamous cell carcinoma and in normal buccal mucosa - an
immunohistochemical study. Cancer Biomark. 7:275–283. 2010.
View Article : Google Scholar : PubMed/NCBI
|
40
|
Langenskiöld M, Ivarsson ML, Holmdahl L,
Falk P, Kåbjörn-Gustafsson C and Angenete E: Intestinal mucosal
MMP-1 - a prognostic factor in colon cancer. Scand J Gastroenterol.
48:563–569. 2013. View Article : Google Scholar : PubMed/NCBI
|
41
|
Hua H, Li M, Luo T, Yin Y and Jiang Y:
Matrix metalloproteinases in tumorigenesis: An evolving paradigm.
Cell Mol Life Sci. 68:3853–3868. 2011. View Article : Google Scholar : PubMed/NCBI
|
42
|
Zhang Z, Tao D, Zhang P, Liu X, Zhang Y,
Cheng J, Yan H, Liu L and Jiang H: Hyaluronan synthase 2 expressed
by cancer-associated fibroblasts promotes oral cancer invasion. Exp
Clin Cancer Res. 35:1812016. View Article : Google Scholar
|
43
|
Panagopoulos V, Leach DA, Zinonos I,
Ponomarev V, Licari G, Liapis V, Ingman WV, Anderson P, DeNichilo
MO and Evdokiou A: Inflammatory peroxidases promote breast cancer
progression in mice via regulation of the tumour microenvironment.
Int J Oncol. 50:1191–1200. 2017. View Article : Google Scholar : PubMed/NCBI
|
44
|
Kuasne H, Barros-Filho MC, Busso-Lopes A,
Marchi FA, Pinheiro M, Muñoz JJ, Scapulatempo-Neto C, Faria EF,
Guimarães GC, Lopes A, et al: Integrative miRNA and mRNA analysis
in penile carcinomas reveals markers and pathways with potential
clinical impact. Oncotarget. 8:15294–15306. 2017. View Article : Google Scholar : PubMed/NCBI
|
45
|
Yokoi A, Yoshioka Y, Yamamoto Y, Ishikawa
M, Ikeda SI, Kato T, Kiyono T, Takeshita F, Kajiyama H, Kikkawa F,
et al: Malignant extracellular vesicles carrying MMP1 mRNA
facilitate peritoneal dissemination in ovarian cancer. Nat Commun.
8:144702017. View Article : Google Scholar : PubMed/NCBI
|
46
|
Ismail TM, Bennett D, Platt-Higgins AM,
Al-Medhity M, Barraclough R and Rudland PS: S100A4 elevation
empowers expression of metastasis effector molecules in human
breast cancer. Cancer Res. 77:780–789. 2017. View Article : Google Scholar :
|
47
|
Sun N-x, Zhao Q, Ye C, Ma Y and Li W: Role
of matrix metal-loproteinase-1 (MMP-1)/protease-activated
receptor-1 (PAR-1) signaling pathway in the cervical cancer
invasion. J Reprod Contracept. 25:18–25. 2014.
|
48
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
49
|
Yang L, Han S and Sun Y: An IL6-STAT3 loop
mediates resistance to PI3K inhibitors by inducing
epithelial-mesenchymal transition and cancer stem cell expansion in
human breast cancer cells. Biochem Biophys Res Commun. 453:582–587.
2014. View Article : Google Scholar : PubMed/NCBI
|
50
|
Tse JC and Kalluri R: Mechanisms of
metastasis: Epithelial-to-mesenchymal transition and contribution
of tumor microenvironment. J Cell Biochem. 101:816–829. 2007.
View Article : Google Scholar : PubMed/NCBI
|
51
|
Huang L, Huang Z, Fan Y, He L, Ye M, Shi
K, Ji B, Huang J, Wang Y and Li Q: FOXC1 promotes proliferation and
epithelial-mesenchymal transition in cervical carcinoma through the
PI3K-AKT signal pathway. Am J Transl Res. 9:1297–1306.
2017.PubMed/NCBI
|
52
|
Shostak K, Zhang X, Hubert P, Göktuna SI,
Jiang Z, Klevernic I, Hildebrand J, Roncarati P, Hennuy B, Ladang
A, et al: NF-κB-induced KIAA1199 promotes survival through EGFR
signalling. Nat Commun. 5:52322014. View Article : Google Scholar
|
53
|
Iida J and McCarthy JB: Expression of
collagenase-1 (MMP-1) promotes melanoma growth through the
generation of active transforming growth factor-beta. Melanoma Res.
17:205–213. 2007. View Article : Google Scholar : PubMed/NCBI
|
54
|
Weiss MB, Abel EV, Mayberry MM, Basile KJ,
Berger AC and Aplin AE: TWIST1 is an ERK1/2 effector that promotes
invasion and regulates MMP-1 expression in human melanoma cells.
Cancer Res. 72:6382–6392. 2012. View Article : Google Scholar : PubMed/NCBI
|
55
|
Shen CJ, Kuo YL, Chen CC, Chen MJ and
Cheng YM: MMP1 expression is activated by Slug and enhances
multi-drug resistance (MDR) in breast cancer. PLoS One.
12:e01744872017. View Article : Google Scholar : PubMed/NCBI
|
56
|
Mueller E, Sarraf P, Tontonoz P, Evans RM,
Martin KJ, Zhang M, Fletcher C, Singer S and Spiegelman BM:
Terminal differentiation of human breast cancer through PPAR gamma.
Mol Cell. 1:465–470. 1998. View Article : Google Scholar : PubMed/NCBI
|
57
|
Zhang YX and Zhao YL: Pathogenic network
analysis predicts candidate genes for cervical cancer. Comput Math
Methods Med. 2016:31860512016. View Article : Google Scholar : PubMed/NCBI
|
58
|
Rajkumar T, Sabitha K, Vijayalakshmi N,
Shirley S, Bose MV, Gopal G and Selvaluxmy G: Identification and
validation of genes involved in cervical tumourigenesis. BMC
Cancer. 11:802011. View Article : Google Scholar : PubMed/NCBI
|